Dynavax Technologies

USA

Dynavax Technologies

2929 Seventh Street, Suite 100

Dino Dina, M.D. – Chief Executive Officer and Director
J. Tyler Martin, M.D. – President, Chief Medical Officer, and Director
Brant Biehn – Vice President
Robert L. Coffman, Ph.D. – Vice President and Chief Scientific Officer
David Happel - Vice President, Global Sales and Marketing
William Heyward, M.D., M.P.H. – Vice President, Clinical Development
Zbigniew Janowicz, Ph.D. – Chief Executive Officer, Dynavax Europe
Christine Larson – Vice President and Chief Financial Officer
Jennifer Lew – Vice President, Finance
Michael S. Ostrach – Vice President, Chief Business Officer and General Counsel
Stephen F. Tuck, Ph.D. – Vice President, Global Technical Operations
William D. Turner – Vice President, Regulatory Affairs and Global Quality
Cecilia Vitug – Vice President, Human Resources

Infectious diseases

Production

Bronchial asthma, Viral hepatitis

DVAX

Arnold L. Oronsky, Ph.D. – Chairman of the Board
Francis R. Cano, Ph.D.
Dennis A. Carson, M.D.
Dino Dina, M.D.
Denise M. Gilbert, Ph.D.
Mark Kessel
Daniel L. Kisner, M.D.
J. Tyler Martin, M.D.
Peggy V. Phillips
Stanley A. Plotkin, M.D.

637.0500

Devices, Technologies, Pharmaceuticals, Chemistry